













270The Feasibility of Angiosome-Targeted
Endovascular Treatment in Patients
with Critical Limb Ischemia and
Foot UlcerKristyna Spillerova, Maria S€orderstr€om, Anders Alb€ack, and Maarit Venermo, Helsinki,
FinlandBackground: To determine wound location according to the angiosome concept and to inves-
tigate the feasibility and success of angiosome-based revascularization in below-the-knee (BTK)
arteries.
Methods: This was a retrospective study of 161 patients (67.5 ± 25.5 years, 66.5% diabetics)
with critical limb ischemia and a foot ulcer, stage Rutherford 5e6, who underwent percutaneous
transluminal angioplasty on BTK arteries in 2012. We evaluated feasibility of angiosome-targeted
revascularization and the number of angiosomes affected by a wound in each patient. Patients
were divided into 3 groups depending on how many BTK vessels were suitable for revasculariza-
tion. The feasibility was analyzed in each group and in relation to number of affected angiosomes.
Results: The wound(s) interfered with one angiosome in only 39 (24.0%) cases. Direct flow
into affected angiosome was successfully achieved in 98 (60.9%) cases. If ulceration was
limited in one angiosome, the targeted revascularisation was possible in 27 cases (69.2%), if
ulceration was extended over 2 angiosomes it was possible in 65 cases (86.7%), if 3 angio-
somes were affected it was possible in 36 cases (85.7%), when 4 angiosomes were affected
the rate dropped to 25.0% and ulceration extended over 5 angiosomes had no possibility of
revascularization.
Conclusions: In critical limb ischemia, the tissue lesion affects several angiosomes in majority
of the cases. In thus far published literature, there is existence of more approaches of
angiosome-targeted revascularization when more than one angiosome is clinically involved
and therefore consensus needs to be achieved for the accurate definition.INTRODUCTION
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Percutaneous transluminal angioplasty (PTA) is
increasingly being used as the first-line revasculari-
zation procedure in CLI. Despite the increasing
endovascular interventions in below-the-knee
(BTK) arteries, nonhealing ulcers remain common
and very often require additional ulcer surgery to
prevent amputation.
Multiple studies about wound healing have been
published over the last decade in vascular literature,
supporting the primary idea that, without pulsatile
flow into the correct foot region, the wound will
fail to heal. In 1987, Ian Taylor et al.1 presented
the angiosome principle in their landmark anatomy
study by dividing the body into 3-dimensional
anatomic blocks of tissue supplied by a specific
artery, the arteriosome.
Fig. 1. (A) Angiosomal distribution used in present
study. (B) Variations of angiosomal distribution. a: Ante-
rior tibial artery and its angiosome; b: peroneal artery and
its angiosome; and c: posterior tibial artery and its angio-
some. 1: Dorsal angiosome, source a ¼ ADP; 2: dorsome-
dial and plantar angiosome, source a ¼ calcanear branch
of ATP; 3: medial plantar instep and forefoot angiosome,
source a ¼ medial plantar artery; 4: lateral plantar foot
and forefoot angiosome, source a ¼ lateral plantar artery;
5: dorsolateral and plantar angiosome, source
a ¼ calcanear branch of fibular artery; 6: lateral malleolar
angiosome, source a ¼ anterior perforating artery (part of
the fibular artery angiosome); and 7: the hallux and
medial side of the second toe angiosome, source
artery ¼ dorsal metatarsal artery (78%), plantar meta-
tarsal artery (22%).
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distribution in foot and concluded that foot con-
tains 6 angiosome regions, each of which supplied
by 1 of the 3 main crural arteries and their
branches (Fig. 1). This knowledge has brought a
new view on revascularization in patients with
critical limb ischemia and so called angiosome-
targeted revascularization, meaning selective
revascularization of the specific artery feeding
the angiosome affected by ulcer, has been stud-
ied.3e7 Several retrospective studies comparing
angiosome-targeted and angiosome-nontargeted
approach in endovascular revascularization have
been carried out, showing promising results in
regard to wound healing and limb salvage in favor
of the angiosome-targeted approach, especially in
the diabetic foot.3e5,8e11
The purpose of this retrospective study was to
evaluate the feasibility of the angiosome theory.
We aimed to answer the questions of (1) how often
the wound is located in more than just 1 angiosome,and (2) how often angiosome-targeted endovascu-
lar revascularization is possible.
MATERIAL AND METHODS
This study was a retrospective analysis of prospec-
tively collected data from a maintained vascular
database (HUSVasc). It included all patients with
CLI, classification Rutherford 5e6 (ischemic ulcer
or gangrene and dry or humid), who underwent
PTA of the arteries BTK during 2012. The angio-
grams of 182 consecutive endovascular procedures
for CLI and tissue lesion were carefully analyzed
before and after PTA and comparison was made
between the anatomy of PTA and the wound loca-
tion. Overall, 22 procedures were excluded because
they either were re-PTA procedures to the same leg
during the same year or the wound location was not
clear. In the end, 161 procedures in 160 patients
were included. One patient underwent procedure
to the both legs.
Fig. 2. (AeC) Angiograms showing the crural arteries
suitable for PTA. (A) One crural artery suitable for
PTA: 90% stenosis in distal anterior tibial artery (ar-
rows); ATP and fibular artery completely occluded with
no distal outflow. (B) Two crural arteries suitable for
PTA: 67% stenosis in distal ATP and a 212-mm long oc-
clusion of the ATA with present outflow distally (ADP
fully patent), fibular artery without any sickness. (Ar-
rows indicate the stenosis suitable for balloon dilata-
tion.) (C) Three crural arteries suitable for PTA: pearl-
like ATA, 95% stenosis in fibular artery and a 57.7-
mm long occlusion in the ATP with present distal
outflow (arrows).
272 Spillerova et al. Annals of Vascular SurgeryThe wound locations were determined using the
clinical notes and photographs stored in our data-
base. As a result of an unclear distribution of the
borderlines between angiosomes, due to the exis-
tence of more than one scheme,2,3,5,12 we decided
to adopt the general scheme of angiosomal distribu-
tion,5 in which borderlines between angiosomes
match those outlined in the recent publication;
angiosomes application in critical limb ischemia in
search for relevance by Alexandrescu13 (Fig. 1A).
We examined the number of crural arteries that
were feasible for endovascular or surgical revascu-
larization according to each patient’s angiogram.
The degree of disease in the crural vessels was
described by using the Society for Vascular Surgery
(SVS)/International Society for Cardiovascular Sur-
gery (ISCVS) scoring system of angiographic appear-
ance as follows: 0, normal or minimal evidence of
disease; 1, 20e49% stenosis; 2, 50e99% stenosis;
2.5, occluded less than halfway, 3, occluded through
most of the length.14 At our clinic, the indication for
PTA is stenosis of at least 50% and patent outflow af-
ter the affection (stenosis and/or occlusion) in the
diseased crural artery (Fig. 2AeC). When the crural
artery fulfilled these criteria, it was considered a
candidate for endovascular treatment.
In the case of long occlusion, the endovascular
treatment is usually attempted but if failed surgical
revascularization is done or patient is scheduled pri-
marily to surgical revascularization. This is always
the case if distal outflow vessel exists. These cases
were counted as feasible for angiosome-targeted
revascularization. In case there was no patent
outflow after the occlusion (pedal arteries not
patent), it was not considered a candidate for
revascularization.
After analyzing the number of BTK arteries
feasible for endovascular treatment, we divided
the patients into 3 groups: group 1 (G1) represent-
ing patients with only 1 crural artery suitable for
revascularization, group 2 (G2) containing patients
with 2 crural arteries fulfilling the conditions for
angioplasty, and group 3 (G3) containing patients
with all 3 crural arteries as an option for revascu-
larization. In each group, we examined the
number of cases in which the targeted revasculari-
zation was feasible and performed, using the defi-
nition of angiosome-targeted revascularization
from the recent publication.5 According to this
definition, the revascularization is targeted if one
of the source arteries leading to the wound area
is open after the procedure even if the wound
spreads over more than one angiosome. Meaning
Table I. Patients characteristics and comorbidities
Patients characteristics Mean value
Age, years 75.8 (42e93)
Glomerular filtration 50.3 (7e<60)
Kreatinin 125.2 (30e668)
CRP 50.5 (3e263)
Number of cases %










Kidney transplantation 7 4.4
Volume 30, January 2016 Angiosome-targeted endovascular treatment 273if the ulceration is located in forefoot (tip of toes)
angiosome-targeted revascularization is considered
as either revascularization of arteria dorsalis pedis
(ADP)/arteria tibialis anterior (ATA) or plantar ar-
tery/arteria tibialis posterior (ATP). If the
ulceration spreads over plantar heel, angiosome-
targeted revascularization is considered if inflow
to either calcanear branch rising from ATP or calca-
near branch rising from fibular artery has been
successfully achieved. This method does not pay
attention to which of the arteries was the major
source for affected area.5,15
In addition, the feasibility of angiosome-targeted
revascularization in relation to number of angio-
somes affected by ulcer, technical success rate, and
the reasons why targeted revascularization was
not achieved were analyzed.
Study was accepted in the ethical committee of
Helsinki University Hospital.
Hypertension 98 61.3
Atrial fibrillation 59 36.9
Coronary artery disease 63 39.4
Hearth failure 24 15.0
Stroke 28 17.5
Pulmonary disease 20 12.5
Rutherford 5 124 77.0
Rutherford 6 37 23.0
CRP, C-reactive protein.
Fig. 3. The number of affected angiosomes in 161 legs.RESULTS
A total of 161 legs (160 patients) undergoing pri-
mary infrapopliteal angioplasty were included. The
mean age of the patients was 75.8 (42e93) and
37.5%were women. Basic demography of the
patients is presented in the Table I. In majority
(n¼ 124; 77%) of the legs, the wound was classified
as Rutherford 5 (Table I).
The wound(s) interfered with 1 angiosome in 39
(24.2%) legs, with 2 angiosomes in 75 (46.6%) legs,
with 3 angiosomes in 42 (26.1%) legs, with 4 angio-
somes in 4 (2.5%) legs, and with 5 angiosomes in 1
(0.6%) legs Figure 3.
Of all extremities, 53 (32.9%) had only 1 crural
artery suitable for revascularization (G1); the
remaining 2 were either without any sign of disease
(n¼17) oroccluded (n¼36)withnopatent outflow.
Two crural arteries (G2) fulfilling the criteria for
revascularization were observed in 88 (54.7%)
legs. In only 20 (12.4%) legs all 3 crural vessels
were suitable for endovascular revascularization
(G3) Table II.
The angiosome-targeted revascularization was
possible in 129 (80.1%) legs and not possible in 32
(19.9%). Of the 129 patients in whom angiosome-
targeted revascularization was possible, it was per-
formed and direct flow achieved in 98 (75.9%)
cases. The reasons for not performing angiosome-
targeted PTA when it was possible (31 cases) were
as follows: (1) it was attempted without success
(n ¼ 9) and another vessel was then revascularized;
(2) the occlusionwas long and should have required
bypass (n ¼ 14), resulting in another vessel beingrevascularized; and (3) unknown reason (n ¼ 8).
Of all 161extremities, the direct flow was achieved
in 98 (60.9%) legs and indirect flow via nontargeted
revascularization in 63 (39.1%) legs Table II.
An analysis of the feasibility and technical suc-
cess rate of targeted revascularization in relation
to wound distribution showed that cases where
wound spread over 2 or 3 angiosome had higher
chance that the source artery will be feasible for
Table II. Feasibility and success rate of targeted revascularization in relation to number of crural arteries
suitable for PTA
Method a








Failed (%) Long occlusion (%) Unknown (%)
1 Crural artery (G1) 53 33 (62.3) 26 (78.8) 2 (6.1) 3 (9.1) 2 (6.1)
2 Crural arteries (G2) 88 76 (86.4) 57 (75.0) 6 (7.9) 8 (10.5) 5 (6.6)
3 Crural arteries (G3) 20 20 (100.0) 15 (75.0) 1 (5.0) 3 (15.0) 1 (5.0)
Total 161 129 (80.1) 98 (75.9) 9 (7.0) 14 (10.9) 8 (6.2)
Table III. Feasibility and success rate of targeted revascularization in relation to wound distribution
274 Spillerova et al. Annals of Vascular Surgeryangiosome-targeted revascularization: if ulceration
was limited in 1 angiosome, the revascularization
was possible in 27 cases (69.2%), if ulceration
was extended to 2 angiosomes it was possible in
65 cases (86.7%), if 3 angiosomes were affected it
was possible in cases 36 (85.7%), if ulceration
was spread over 4 angiosomes it was possible in 1
of 4 cases, and ulceration spread over 5 angiosome
(n ¼ 1) had no possibility of revascularization,
detailed presented in Table III.DISCUSSION
The importance of angiosome-targeted revasculari-
zation has been lively discussed during recent years.
Quite a few studies have found targeted revascular-
ization an important factor associated with wound
healing, but opposite opinions also exist.16 We stud-
ied the feasibility of angiosome-targeted revascular-
ization in the endovascular treatment of critical limbischemia and tissue lesions. Our findings show, that
the wound(s) are not located only in one angiosome
but that, more likely, they affect several angio-
somes. Furthermore in every third patient, there
was only one crural artery suitable for revascu-
larization. However, in majority of the patients
angiosome-targeted revascularization seems to be
possible.
The reason for why 2 or more angiosomes are
affected is most often the fact that the wound is
located on the borderline of 2 or even more angio-
somes or that the patient suffers from more than
one ulcer in the foot. When examining previous
studies,4,5,10,17 we lacked the definition of the
angiosome-targeted approach in those cases where
the wound spreads over more angiosome regions.
In a study by Lida et al. targeted revascularization
was defined as an open line from the abdominal
aorta to the artery supplying the angiosome where
the wound was located, with nomention of strategy
for cases with ulcer affecting 2 ormore angiosomes.4
Volume 30, January 2016 Angiosome-targeted endovascular treatment 275The study done by S€oderstr€om et al.5 points out that
the wound can be located across more than one
angiosome, but do not provide clear definition of
targeted revascularization in those cases.
In cases where wound spread over more angio-
somes the conventional method used in most of
the publications consider as angiosome-targeted
approach if any angiosomal artery involved in the
wound area is opened after procedure.5 That allows
the clinician to choose from more than 1 crural
artery, and thus, there is higher possibility to achieve
targeted revascularization. Such an approach may
be based on knowledge from a Japanese anatomic
study,18 which demonstrated that in 78% of cases,
the blood supply to the forefoot is received from
the first dorsal metatarsal artery (rising from ADP)
and only in 22% from the first plantarmetatarsal ar-
tery (rising from lateral plantar artery).
Alexandrescu13 recently presented another
angiosome-targeted approach, which targets only
posterior tibial artery and its terminal branches if
the wound is located in forefoot or the heel. This
would most probably lead to a lowered probability
that angiosome artery will be a possible candidate
for endovascular treatment as it results in only 1
crural artery being a choice. Such an approach
may be based on knowledge that in 12% of popula-
tion, the ADP is extremely thinned or absent.3,6,18
In the present study, although there was distal
outflow to the angiosome that was affected by a
wound, revascularization was not performed in
20.0% (n ¼ 31) of the cases. In about half of the
cases, the approach was attempted without success
and an easier artery was then selected; and in about
one-third of cases it was not even attempted because
of a long lesion, and a vessel providing easier revas-
cularizationwas selected. In these cases, angiosome-
targeted revascularization could have been achieved
with open surgical bypass. In 8 cases (25.8%), there
was no explanation as to why targeted revasculari-
zation was not preformed and another artery was
revascularized instead, although the targeted revas-
cularization seemed possible according to the angio-
grams recorded. The most probable explanation is a
poor knowledge of the anatomy of wound location.
When the treatment policy is ‘‘endovascular
first’’, it seems that we have to accept a certain num-
ber of nontargeted revascularizations, instead of
treating suitable cases by targeted bypass.
The limitation of our study and the other studies
on this topic is related to the angiosomal distribu-
tion. Because of multiple anatomic variations in
the foot arteries,3,6 the general scheme of angioso-
mal distribution cannot be taken for granted in the
case of every patient. The diversity of thedistribution is well demonstrated in Attinger’s study
from 2006 where he found and described 2 major
variations in the perfusion of the plantar heel and
plantar forefoot.2 Furthermore, some of the authors
have even considered the hallux and middle side of
the second toe as a separate angiosome3,12 (Fig. 1).
Therefore, a patient’s anatomy should be examined
carefully and considered in the decision of which
artery should be revascularized. This may become
problematic, if not impossible, in patients with a
so-called desert foot (no patency of pedal arteries
on angiogram).
Although we think that the angiosome concept is
very logical and has considerable a lot of potential,
we still face uncertainties in definitions and angio-
some borders distribution when trying to apply it
to treatment of CLI.
This study was retrospective, and the wound
locationswereextracted fromcase records.Although
wound location has been carefully reported in our
institution ever since the emergence of the interest
in angiosomes and wound location appeared in the
literature, the determination of the affected angio-
some can be difficult in some cases. Photographs
were included in the case histories ofmany of the pa-
tients included in the present study, which was very
helpful. Moreover, in some cases, the evaluation of
angiograms may be problematic because of the
poor quality of the images as regards limitations in
the examined region.
A well planned prospective study where the
wound location is defined precisely, high quality
angiogram with the information on collaterals and
the patency of pedal arch is definitely needed.CONCLUSIONS
In critical limb ischemia, the tissue lesion affects
several angiosomes in majority. There is existence
of more angiosome-targeted approaches, and there-
fore, consensus needs to be achieved for the
accurate definition of angiosome-targeted revascu-
larization when more than one angiosome is clini-
cally involved.REFERENCES
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